Structural features associated with reactive metabolite formation in clozapine analogues

Area of Science:

• Pharmacology
• Toxicology
• Medicinal Chemistry

Background:

• Clozapine is linked to agranulocytosis, a severe drop in white blood cells.
• Previous research suggests clozapine is oxidized to a reactive metabolite by granulocytes, causing cell damage.

Purpose of the Study:

• To test the hypothesis that a nitrogen bridge in clozapine analogs is crucial for forming reactive metabolites.
• To evaluate if analogs lacking this feature are less likely to form such metabolites.

Main Methods:

• Oxidation of clozapine analogs with varying bridge structures (nitrogen, oxygen, sulfur) using hypochlorous acid (HOCl), myeloperoxidase, and activated neutrophils.
• Trapping of reactive intermediates with glutathione to detect their formation.

Main Results:

• Clozapine analogs with a nitrogen bridge formed reactive intermediates upon oxidation, which were trapped by glutathione.
• Analogs with oxygen or sulfur bridges did not show evidence of reactive intermediate formation under similar oxidation conditions.

Conclusions:

• The nitrogen bridge is critical for the formation of reactive metabolites from clozapine analogs during oxidation.
• This finding supports a potential screening method to predict agranulocytosis risk early in drug development.